Madras Fertilize (MADRASFERT)

FairStock Score: 18/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding is high at 85.27%, giving management a concentrated stake in the company's future.
• Latest quarter is positive: net profit of ₹3 Cr on sales of ₹419 Cr, so the company is not currently loss-making.
• ROCE of 10.78% shows the business can generate some operating return despite its problems.
• The latest quarter sales of ₹419 Cr indicate a sizeable operating base.

Concerns

• Valuation is extreme: P/E of 153.31 and P/B of 44.78, with book value only ₹1.53 per share.
• Financial leverage is dangerous: debt/equity ratio of 23.64 leaves a very thin equity cushion.
• Business is deteriorating sharply: sales down 47.61% and profit down 96.62%, with zero dividend yield.
• Piotroski F-Score is just 3/9 and FairStock Score is 0/100, indicating weak financial health and high risk.

AI Analysis

At ₹68.51, this is not the kind of asymmetric bargain I look for. Madras Fertilizers earns a P/E of 153.31 and price-to-book of 44.78 against a book value of just ₹1.53. For that multiple, I would expect a durable franchise, but there is no evidence of one. Sales have fallen 47.61% and profit is down 96.62%; latest quarter net profit of ₹3 Cr on ₹419 Cr sales is wafer-thin. A Piotroski F-score of 3/9 reinforces my suspicion: financial health is weak, not improving. The fertilizer business is cyclical and policy-driven. The company has a debt/equity ratio of 23.64, which means the equity cushion is tiny and leverage is frightening. Dividend yield is zero, so I am not being paid to wait. ROCE of 10.78% sounds okay at first, but when debt is this high and book value is ₹1.53, the risk to equity holders is enormous. ROE is not even meaningful, which tells me current profitability is not a reliable base for valuation. What do I like? Promoter holding is 85.27%, which gives management a large stake in the outcome. The latest quarter is positive, so the decline has not yet killed the company. But with FairStock Score 0/100 and sales/profit collapsing, this is a turnaround or cyclical bet, not a predictable compounding machine. I cannot value it on earnings because earnings have collapsed. I cannot value it on book because book is negligible. The price has fallen from the 52-week high of ₹96.39 to ₹68.51, but a falling price is not automatically cheap. For a value investor, the margin of safety must come from a sound balance sheet and stable earning power; this stock offers neither. I would leave it on the 'too hard' pile and wait for better numbers.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer